
No actionable public-market trade is identified: SpaceX and Cometeer are private, and the discussion provides no valuation or investment terms. Treat the Alzheimer’s research—including the ADSMART trial—as early-stage developments, not established investment opportunities; no investible ticker or stock recommendation was provided.

By @thediaryofaceo
64% of our viewers don't realise they don't subscribe, please double check, thank you!!